From the Wires
MorphoSys to Host Conference Call on Bio-Rad's planned Acquisition of MorphoSys's Research and Diagnostic Antibody Business AbD Serotec
By: Marketwired .
Dec. 17, 2012 01:40 AM
MARTINSRIED, GERMANY and MUNICH, GERMANY -- (Marketwire) -- 12/17/12 -- MorphoSys AG / MorphoSys to Host Conference Call on Bio-Rad's planned Acquisition of MorphoSys's Research and Diagnostic Antibody Business AbD Serotec.
Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Today at 2:00 p.m. CET (1:00 p.m. GMT, 8:00 a.m. EST), the Management Board of MorphoSys AG will host a public conference call and webcast to present information on Bio-Rad's planned acquisition of MorphoSys's research and diagnostic antibody business AbD Serotec.
Germany: +49 (0) 89 2444 32975
For U.K. residents: +44 (0) 20 3003 2666
For U.S. residents: +1 202 204 1514
An audio replay and manuscripts of the conference will be available on www.morphosys.com/conference-calls in due course.
MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare. Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 70 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit http://www.morphosys.com
Slonomics® is a registered trademark of Sloning BioTechnology GmbH, a subsidiary of MorphoSys AG.
Conference Call Alert (PDF):
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: MorphoSys AG via Thomson Reuters ONE
For more information, please contact:
Latest AJAXWorld RIA Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week